Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Harvard Bioscience (HBIO) Change in Cash (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Change in Cash for 16 consecutive years, with $1.8 million as the latest value for Q4 2025.

Quarterly Change in Cash rose 489.8% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 2674.86% year-over-year, with the annual reading at $4.5 million for FY2025, 2674.86% up from the prior year.
Change in Cash for Q4 2025 was $1.8 million at Harvard Bioscience, up from -$625000.0 in the prior quarter.
The five-year high for Change in Cash was $2.3 million in Q4 2021, with the low at -$2.5 million in Q1 2021.
Average Change in Cash over 5 years is $14850.0, with a median of -$117500.0 recorded in 2024.
The sharpest move saw Change in Cash tumbled 489.27% in 2021, then soared 5235.71% in 2025.
Over 5 years, Change in Cash stood at $2.3 million in 2021, then tumbled by 127.98% to -$636000.0 in 2022, then tumbled by 66.19% to -$1.1 million in 2023, then surged by 56.39% to -$461000.0 in 2024, then skyrocketed by 489.8% to $1.8 million in 2025.
According to Business Quant data, Change in Cash over the past three periods came in at $1.8 million, -$625000.0, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.